Centiva Capital’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,905
| Closed | -$231K | – | 1422 |
|
|
2024
Q4 | $231K | Sell |
4,905
-1,595
| -25% | -$75K | ﹤0.01% | 985 |
|
|
2024
Q3 | $343K | Sell |
6,500
-11
| -0.2% | -$581 | 0.01% | 1005 |
|
|
2024
Q2 | $353K | Sell |
6,511
-9,989
| -61% | -$541K | 0.01% | 966 |
|
|
2024
Q1 | $1.16M | Buy |
16,500
+16,205
| +5,493% | +$1.14M | 0.03% | 369 |
|
|
2023
Q4 | $24.6K | Sell |
295
-3,218
| -92% | -$269K | ﹤0.01% | 1162 |
|
|
2023
Q3 | $103K | Buy |
+3,513
| New | +$103K | ﹤0.01% | 1050 |
|
|
2023
Q2 | – | Sell |
-9,155
| Closed | -$322K | – | 1266 |
|
|
2023
Q1 | $322K | Buy |
+9,155
| New | +$322K | 0.01% | 664 |
|